E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/30/2011 in the Prospect News PIPE Daily.

Emisphere Technologies plans $7.5 million private placement of units

Roth Capital Partners is agent for deal; MHR Fund among the investors

By Devika Patel and Stephanie N. Rotondo

Knoxville, Tenn., June 30 - Emisphere Technologies, Inc. arranged a private placement of units to raise $3.75 million on June 29, according to an 8-K filed Thursday with the Securities and Exchange Commission. It also negotiated a second deal for the same amount with MHR Fund Management LLC. Roth Capital Partners is the agent.

The company will sell 4,300,438 common shares at $0.872 apiece, along with warrants. The warrants and shares will be sold in units of one common share and a warrant for 0.7 of a share. The price per share is a 19.26% discount to $1.08, the June 28 closing share price.

The warrants are exercisable at $1.09 for five years. The strike price reflects a 0.93% premium to the June 28 closing price.

The company also announced that it has negotiated a separate securities purchase agreement with MHR for a separate private placement of identical units. This deal will raise about $3.75 million as well through the sale of about 4.3 million units at the same price.

Michael R. Garone, interim chief executive and chief financial officer, told Prospect News that Emisphere elected to do the financing "because we were running out of cash."

Garone added that the terms of the deal were "very good" and that the company had received "good support" from its banker.

In connection with the deal, MHR waived certain anti-dilution adjustment rights under its 11% senior secured notes and certain warrants that would otherwise have been triggered by the private placement. As consideration for the waiver, MHR will also receive a warrant for 795,000 shares that will be reimbursed for up to $25,000 of its legal fees. The warrant has identical terms to those sold in the offering.

Proceeds will be used to fund the company's operations, including new product development and commercialization, and meet the company's obligations as they may arise.

Tarrytown, N.Y.-based Emisphere is a biopharmaceutical company.

Issuer:Emisphere Technologies, Inc.
Issue:Units of one common share and a warrant for 0.7 of a share
Amount:$7.5 million
Units:8,600,876
Price:$0.872
Warrants:One warrant for 0.7 of a share per unit
Warrant expiration:Five years
Warrant strike price:$1.09
Agent:Roth Capital Partners
Investor:MHR Fund Management LLC (for about $3.75 million)
Pricing date:June 29
Stock symbol:OTCBB: EMIS
Stock price:$1.10 at close June 29
Market capitalization:$47.91 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.